The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Alert/Advisory (1066)
- (-) Over the counter (OTC) medicines (13)
- (-) Weight loss products (1)
- Medicine safety (493)
- Medical devices safety (343)
- Safety (61)
- Regulatory compliance (23)
- Import and export (18)
- Prescription medicines (16)
- Listed medicines (15)
- Therapeutic goods regulation (14)
- Australian Register of Therapeutic Goods (ARTG) (11)
- Complementary medicines (11)
- Shortages (11)
- Blood safety (8)
- Non-prescription medicines (6)
- Advertising (4)
- Labelling and packaging (3)
- Sunscreens (3)
- Breast implant hub (2)
- Legislation (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Search
1068 result(s) found, displaying 1 to 25
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Safety alertsAcne medication warnings further highlight potential risks of mood-related changes and sexual disorders.
-
Safety alertsWe are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.
-
Safety alertsFurther examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Safety alertsMagnum XXL capsules pose a serious risk to your health and should not be taken.
-
Market actionsSeveral vitamin and perinatal (including preconception) products are being recalled due to a lack of or excessive levels of potassium iodine.
-
Market actionsReynard Health Supplies is conducting a Critical Recall of the above products. A contamination problem has been identified with the products.
-
Safety alertsMore prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.
-
Safety alertsPossible risk of learning, communication and behaviour problems in children born to men taking this medicine.
-
Safety alertsExtra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes
-
Market actionsBoston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Market actionsCaruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.
-
Safety alertsGold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Safety alertsDynamint X tablets pose a serious risk to your health and should not be taken.
-
Safety alertsMAXMAN tablets pose a serious risk to your health and should not be taken.
-
Medicine shortage alertsDue to the concerns and difficulties caused by such shortages, we are giving patients and prescribers early notification so that they can plan ahead.
-
Medicine shortage alertsPharmacists may dispense alternative brands or strengths without a new prescription.
-
Safety alertsThe oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
Safety alertsAfrican Vigorous Max Strength poses a serious risk to your health and should not be taken.
-
Safety alertsWe have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
-
Safety alertsZiyinzhuangyang tablets pose a serious risk to your health and should not be taken.
-
Safety alertsConsumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
-
Safety alertsWe have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »